The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Open accessAbstract
The CDK inhibitor p21 (WAF-1/CIP-1/SDI-1) has been implicated in DNA damage-induced p53-mediated G1 arrest, as well as in physiological processes, such as cell differentiation and senescence, that do not involve p53 function. To determine the impact of p21 on normal development and cell-cycle regulation in vivo, we have generated transgenic mice that abundantly express p21 specifically in hepatocytes. During postnatal liver development, when transgenic p-21 protein becomes detectable, hepatocyte proliferation is inhibited dramatically. This disturbance causes a reduction in the overall number of adult hepatocytes, resulting in aberrant tissue organization, runted liver and body growth, and increased mortality. The transgenic p21 protein is associated with most, if not all, of the cyclin D1-CDK4 in liver but not significantly with other cyclin/CDK proteins, indicating the importance of cyclin D1-CDK4 function in normal liver development. The appearance of large polyploid nuclei in some hepatocytes indicates that p21 may also cause arrest during the G2 phase of the cell cycle. Significantly, partial hepatectomy failed to stimulate hepatocytes to proliferate in p21 transgenic animals. These results provide the first in vivo evidence that appropriate p21 levels are critical in normal development and further implicate p21 in the control of multiple cell-cycle phases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The proliferation of p21 positive hepatocytes is irreversibly inhibited49 making it unlikely that p21 positive hepatocytes contribute to regeneration here.”
From Hepatic progenitor cells of biliary origin with liver repopulation capacity (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Experimental pathology of the liver
Higgins, G. (1931) · Medical Entomology and Zoology · Cited by 4,057
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,288
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,675
Flagged first, then by citations
Research works printed but not linked: 3
- 10.1128/MCB.6.12.4697 · DOI
- 1992, The liver as a stem cell lineage system., Am. J. Physiol., 263, 139
- 1994, Induction of p21 (WAF1/CIP1) during differentiation., Oncogene, 9, 3389
Cited by
Sorted by citations
Items 201–234 of 234
Sawada, N., Kojima, T., Obata, H., Isomura, H., Atsumi, S., Sawaki, M., Tsuzuki, N., Tobioka, H., Kokai, Y., Satoh, M., et al. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03117.x · Cited by 5
Hua, Q.-H., Zhang, X., Tian, R., She, Z., & Huang, Z. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400127 · Cited by 4
Cell Cycle Control in the Liver
Albrecht, J. H., & Mullany, L. K. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch62 · Cited by 4
Wu, S., Guo, W., Liang, S., Lü, H., Sun, W., Ren, X., Sun, Q., & Yang, X. (2018) · Scientific Reports · doi:10.1038/s41598-017-18674-3 · Cited by 3
Regulation of Cell Cycle During Liver Regeneration
Nevzorova, Y. A., & Trautwein, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00011-7 · Cited by 3
Changes in Hepatocyte Ploidy During Liver Regeneration
Duncan, A. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00012-9 · Cited by 3
The Regulation of Tumor Suppressor Genes by Oncogenes
Dent, P., Qiao, L., Gilfor, D., Birrer, M. J., Grant, S., & Fisher, P. B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:269 · Cited by 3
Characterization of Hepatocytes and Their Use as a Model System in Toxicogenomics *
Baker, T. K., Higgins, M. A., Carfagna, M. A., & Ryan, T. P. (2003) · CRC Press eBooks · doi:10.1201/9780203504819-7 · Cited by 3
Cancer Gene Therapy with Tumor Suppressor Genes Involved in Cell-Cycle Control
Meng, R. D., & El‐Deiry, W. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50018-5 · Cited by 2
Trautwein, C. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50007-3 · Cited by 2
Alison, M. R., Golding, M., Emons, V. E., Anilkumar, T. V., & Sarraf, C. (1998) · Medical Molecular Morphology · doi:10.1007/bf01557781 · Cited by 2
Gene Expression Profile Databases in Toxicity Testing
Dunn, R. T., & Kolaja, K. L. (2003) · CRC Press eBooks · doi:10.1201/9780203504819-11 · Cited by 1
Naito, A., Roberts, R. A., & Dragan, Y. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01403-2 · Cited by 1
Regulation of the Liver Cell Mass
Malek, N. P., Rudolph, K. L., & Diehl, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2e · Cited by 1
Expression of p21wafl/cipl Is Induced in the Rat Liver by Feeding of 2-Acetylaminofluorene
Watanabe, T., Ozaki, M., Kawasaki, H., Kojima, T., & Sawada, N. (1998) · Journal of Toxicologic Pathology · doi:10.1293/tox.11.191 · Cited by 1
Mechanisms of Cell Growth and Tissue Repair
Clément, A., & Brody, J. S. (1999) · Springer eBooks · doi:10.1007/978-1-4614-7537-8_10 · Cited by 1
Koteish, A. A., Yang, S., Lin, H., Huang, J., & Diehl, A. M. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200211000-00015 · Cited by 66
Regulation of Cell Division in Higher Eukaryotes
Martínez, F., Chávez, A. D., González, D., & Gutierrez, A. A. (2001) · Elsevier eBooks · doi:10.1016/b978-0-08-057455-4.50085-2
Liver damage using suicide genes: a model for oval cell activation
Bustos, M., Beraza, N., Alzuguren, P., Gil, A. G., Sangro, B., & Prìeto, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)81711-6
Investigating the role of Bmi-1 in liver growth and function
Elder, A. K. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M. B., Mehal, W. Z., & Friedman, S. L. (2004)
Nottrodt, R. E. (2016) · Brock University Digital Repository (Brock University)
Analysis of the VEGFR1 (FLT-1) Isoforms in Vascular Development
Kappas, N. C. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/b1ya-7d17
Naito, A., Roberts, R. A., & Dragan, Y. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100601-6.95689-8
Estrogen-Induced Proliferation in Cultured Hepatocytes Involves Cyclin D1, P21 CIP1
Barone, M., Ladisa, R., Leo, A. D., Spano, D., Francioso, D., Aglio, V., Amoruso, A., Francavilla, A., & Iolascon, A. (2006)
Cloning and expression profile of FLT3 gene during rat liver regeneration
Aydin, I. T. (2005) · Bilkent University Institutional Repository (Bilkent University)
Age-dependent transcriptional and epigenetic alterations in mouse hepatocytes
Sharma, A. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155390
Hesketh, R. (1997) · Elsevier eBooks · doi:10.1016/b978-012344548-3/50094-7
Characterization of Hepatocytes and Their Use as a Model System in Toxicogenomics
Baker, T. K., Higgins, M. A., Carfagna, M. A., & Ryan, T. (2003) · Informa Healthcare eBooks · doi:10.1201/9780203504819.ch7
Naito, A., Roberts, R. A., & Dragan, Y. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95689-7
Gene Expression Profile Databases in Toxicity Testing
Dunn, R. T., & Kolaja, K. L. (2003) · Informa Healthcare eBooks · doi:10.1201/9780203504819.sec5
Achudhan, D., Orme, J. J., Sharma, R., Komel, A., Khan, K. G., White, T. A., LeBrasseur, N. K., Khosla, S., Park, S. S., Pignolo, R. J., et al. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag122 · Cited by 1
(1999) · PubMed · Cited by 171
Metadata
- Authors
- Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-02-01
- Volume
- 10
- Issue
- 3
- Pages
- 245-260
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W4300612151
- Cited by
- 234
- References
- 75
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 1
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (5r01dk042910-04)
- National Cancer Institute (R01CA065572, CA 65572, R01CA046283, CA-46283)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-42910)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- p21, cyclin-dependent kinase inhibitors, hepatocytes, postnatal liver development, liver regeneration, cell cycle arrest, cyclin D1/CDK4, hepatocyte proliferation, transgenic mice, partial hepatectomy, G2 cell cycle arrest, polyploidy, p53-independent function
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Division, DNA, Enzyme Inhibitors, Hepatectomy, Liver, Liver Regeneration, Mice, Transgenic, Molecular Sequence Data, Prealbumin, Proto-Oncogene Proteins, Oncogene Proteins, Cyclins, Gene Targeting, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
